Wokmont-A Tablet SR is a combination medication containing Acebrophylline 200 mg and Montelukast 10 mg, formulated to provide sustained relief in respiratory conditions characterized by bronchoconstriction, inflammation, and mucus hypersecretion. Acebrophylline, a bronchodilator with mucolytic and anti-inflammatory properties, facilitates airway relaxation and improves mucus clearance, thereby enhancing pulmonary function in obstructive airway diseases such as chronic bronchitis and asthma. Montelukast, a leukotriene receptor antagonist, inhibits the action of leukotrienes that contribute to airway inflammation, bronchoconstriction, and edema, thus reducing asthma symptoms and preventing exercise-induced bronchospasm. The sustained-release formulation ensures prolonged therapeutic levels, improving patient compliance by reducing dosing frequency. Wokmont-A Tablet SR is indicated for the management and prophylaxis of chronic respiratory diseases including asthma and chronic obstructive pulmonary disease (COPD), where both bronchospasm and inflammation are present. It should be used under medical supervision, with caution in patients with hepatic impairment or hypersensitivity to any component. Adverse effects may include headache, gastrointestinal disturbances, and rare hypersensitivity reactions. Regular monitoring and adherence to prescribed dosage are essential to achieve optimal therapeutic outcomes and minimize potential side effects.